ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC

ورودی‌های بالینی بیمار

حداقل ۴۰ — حداکثر ۷۹ • واحد: years

حداقل ۱۳۰ — حداکثر ۳۲۰ • واحد: mg/dL

حداقل ۲۰ — حداکثر ۱۰۰ • واحد: mg/dL

حداقل ۹۰ — حداکثر ۲۰۰ • واحد: mmHg

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
ascvd risk
—%
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–5
  • Borderline Risk5–7.5
  • Intermediate Risk7.5–20
  • High Risk20–100
Direct Clinical Answer

The ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Estimates the 10-year risk of atherosclerotic cardiovascular disease (heart attack, stroke, or death due to coronary heart disease or stroke) using the Pooled Cohort Equations. For patients 40-79 years old with no history of ASCVD.

Clinical Indication

The ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC is indicated for bedside clinical practice to support Estimates the 10-year risk of atherosclerotic cardiovascular disease (heart attack, stroke, or death due to coronary heart disease or stroke) using the Pooled Cohort Equations. For patients 40-79 years old with no history of ASCVD.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring. Clinical exclusion: Not applicable to patients with prior ASCVD, LDL-C ≥190 mg/dL, or age outside 40-79 years.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: USPSTF recommends statin therapy for ages 40-75 with ≥1 CVD risk factor and 10-year risk ≥10%.

Formula & Variables:

10-year ASCVD risk = 1 - S₀(t)^exp(Xβ - mean Xβ), where S₀(t) is the baseline survival, Xβ is the sum of coefficient × value for each risk factor, with race- and sex-specific coefficients

Input Parameters

NameTypeRequiredDescription
ageintegerYesPatient's age in years (must be between 40 and 79)(years)
sexstringYesPatient's biological sex
racestringYesPatient's race (White or African American)
total_cholesterolfloatYesTotal cholesterol level(mg/dL)
hdl_cholesterolfloatYesHDL cholesterol level(mg/dL)
systolic_bpintegerYesSystolic blood pressure(mmHg)
bp_treatmentbooleanYesCurrently on blood pressure lowering medication
diabetesbooleanYesHistory of diabetes mellitus
smokerbooleanYesCurrent smoker (cigarettes, cigars, or pipe)

Score Interpretation & Guidance

RangeStageDescription
0–5Low Risk<5% 10-year risk
5–7.5Borderline Risk5% to <7.5% 10-year risk
7.5–20Intermediate Risk7.5% to <20% 10-year risk
20–100High Risk≥20% 10-year risk

Evidence-Based References (EBM)

  • Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73.
  • Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45.
  • Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646.

Related calculators